POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	1s1d	APYRASE (Homo sapiens)	5 / 11	ALA A  38 LEU A 100 LEU A  59 LEU A  84 ALA A  41	None	1.17A	18.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	1tf0	SERUM ALBUMIN (Homo sapiens)	10 / 11	PHE A 211 ALA A 215 LEU A 219 ARG A 222 LEU A 238 HIS A 242 ARG A 257 LEU A 260 SER A 287 ALA A 291	None None None CIT  A2001 ( 2.9A) DKA  A1003 (-4.3A) DKA  A1003 (-3.7A) DKA  A1003 (-4.1A) None None CIT  A2001 ( 3.9A)	0.74A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	1tf0	SERUM ALBUMIN (Homo sapiens)	10 / 11	PHE A 211 TRP A 214 ALA A 215 LEU A 219 ARG A 222 HIS A 242 ARG A 257 LEU A 260 SER A 287 ALA A 291	None None None None CIT  A2001 ( 2.9A) DKA  A1003 (-3.7A) DKA  A1003 (-4.1A) None None CIT  A2001 ( 3.9A)	0.83A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	1wwx	E74-LIKE FACTOR 5 ESE-2B (Homo sapiens)	5 / 11	ALA A  68 LEU A  11 LEU A  69 SER A  44 ALA A  48	None	1.11A	8.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	2c2n	MALONYL COA-ACYL CARRIER PROTEIN TRANSACYLASE (Homo sapiens)	5 / 11	ALA A 248 LEU A 249 LEU A 245 LEU A 284 SER A 117	None	1.08A	21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	2jii	SERINE/THREONINE-PRO TEIN KINASE VRK3 MOLECULE: VACCINIA RELATED KINASE 3 (Homo sapiens)	5 / 11	ALA A 240 LEU A 324 LEU A 290 LEU A 376 ALA A 309	None	1.14A	20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	2of5	LEUCINE-RICH REPEAT AND DEATH DOMAIN-CONTAINING PROTEIN (Homo sapiens)	5 / 11	ALA H 856 LEU H 857 LEU H 853 LEU H 787 ALA H 796	None	1.01A	11.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	3pg6	E3 UBIQUITIN-PROTEIN LIGASE DTX3L (Homo sapiens)	5 / 11	ALA A 662 LEU A 664 HIS A 707 ARG A 729 SER A 725	None	1.14A	12.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	4ern	TFIIH BASAL TRANSCRIPTION FACTOR COMPLEX HELICASE XPB SUBUNIT (Homo sapiens)	5 / 11	LEU A 662 LEU A 547 HIS A 551 LEU A 693 ALA A 508	None	1.09A	18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	4hbq	MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1 (Homo sapiens)	5 / 11	ALA A 139 LEU A 129 LEU A 103 SER A  99 ALA A 111	None	1.13A	15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	5a31	ANAPHASE-PROMOTING COMPLEX SUBUNIT 1 ANAPHASE-PROMOTING COMPLEX SUBUNIT 5 (Homo sapiens)	5 / 11	ALA O 630 LEU O 634 LEU O 601 LEU A1787 ALA A1792	None	0.97A	22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	5lf8	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 17 (Homo sapiens)	5 / 11	PHE A 284 LEU A 184 LEU A 163 LEU A  49 ALA A  59	None None None None EMC  A 402 ( 4.1A)	1.01A	20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	5mc5	XAA-PRO DIPEPTIDASE (Homo sapiens)	5 / 11	ALA A 425 LEU A 435 LEU A 359 LEU A 338 SER A 350	None	1.13A	9.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	5v8j	CYCLIC GMP-AMP SYNTHASE (Homo sapiens)	5 / 11	ALA A 323 LEU A 322 LEU A 324 LEU A 262 ALA A 273	None	1.15A	21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	5wu3	SPECKLE TARGETED PIP5K1A-REGULATED POLY(A) POLYMERASE (Homo sapiens)	5 / 11	ALA A 560 LEU A 563 LEU A 539 LEU A 512 ALA A 433	None	1.11A	22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H9Z_A_RWFA3001_1 (SERUM ALBUMIN)	6co2	NUDT16-TUDOR-INTERAC TING (NUDT16TI) (Homo sapiens)	5 / 11	PHE A 111 ALA A 175 LEU A 176 LEU A 172 LEU A 160	None	1.15A	8.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BXD_A_RWFA2001_1 (SERUM ALBUMIN)	1tf0	SERUM ALBUMIN (Homo sapiens)	9 / 9	TYR A 150 LYS A 199 PHE A 211 ARG A 222 LEU A 238 HIS A 242 ARG A 257 LEU A 260 ALA A 291	DKA  A1003 (-4.4A) CIT  A2001 ( 2.7A) None CIT  A2001 ( 2.9A) DKA  A1003 (-4.3A) DKA  A1003 (-3.7A) DKA  A1003 (-4.1A) None CIT  A2001 ( 3.9A)	0.38A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BXD_B_RWFB2001_1 (SERUM ALBUMIN)	1tf0	SERUM ALBUMIN (Homo sapiens)	8 / 10	TYR A 150 LYS A 199 PHE A 211 ARG A 222 LEU A 238 HIS A 242 ILE A 290 ALA A 291	DKA  A1003 (-4.4A) CIT  A2001 ( 2.7A) None CIT  A2001 ( 2.9A) DKA  A1003 (-4.3A) DKA  A1003 (-3.7A) DKA  A1003 ( 4.5A) CIT  A2001 ( 3.9A)	0.31A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BXD_B_RWFB2001_1 (SERUM ALBUMIN)	1tf0	SERUM ALBUMIN (Homo sapiens)	8 / 10	TYR A 150 LYS A 199 PHE A 211 TRP A 214 ARG A 222 HIS A 242 ILE A 290 ALA A 291	DKA  A1003 (-4.4A) CIT  A2001 ( 2.7A) None None CIT  A2001 ( 2.9A) DKA  A1003 (-3.7A) DKA  A1003 ( 4.5A) CIT  A2001 ( 3.9A)	0.64A	100.00